Bio-Rad Monolisa HCV Ag-Ab ULTRA V2 - HSA Registration DE0014864
Access comprehensive regulatory information for Bio-Rad Monolisa HCV Ag-Ab ULTRA V2 in the Singapore medical device market through Pure Global AI's free database. This CLASS D IVD medical device is registered under HSA registration number DE0014864 and owned by Bio-Rad. The device was registered on February 28, 2014.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Monolisa HCV Ag-Ab ULTRA V2 assay is a semi- quantitative enzyme immunoassay kit for the detection of Hepatitis C Virus (HCV) core antigen and antibodies in human serum or plasma specimens. This kit can be used for the screening of blood donations and as an aid in the diagnosis of hepatitis C infection. The Monolisa HCV Ag-Ab ULTRA V2 assay can be used manually or on automated systems.

